NO20021086L - Anordning for forsinket frigivelse av anti-aknemiddel - Google Patents

Anordning for forsinket frigivelse av anti-aknemiddel

Info

Publication number
NO20021086L
NO20021086L NO20021086A NO20021086A NO20021086L NO 20021086 L NO20021086 L NO 20021086L NO 20021086 A NO20021086 A NO 20021086A NO 20021086 A NO20021086 A NO 20021086A NO 20021086 L NO20021086 L NO 20021086L
Authority
NO
Norway
Prior art keywords
carrier
acne
formulation
delayed release
acne agent
Prior art date
Application number
NO20021086A
Other languages
English (en)
Other versions
NO20021086D0 (no
Inventor
Fotinos Spiros
Original Assignee
Lavipharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1997/003209 external-priority patent/WO1997048387A1/en
Publication of NO20021086L publication Critical patent/NO20021086L/no
Application filed by Lavipharm Sa filed Critical Lavipharm Sa
Publication of NO20021086D0 publication Critical patent/NO20021086D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/12Keratolytics, e.g. wart or anti-corn preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Oppfinnelsen tilveiebringer en anordning i form av en lapp for topisk applikasjon av en anti-aneformulering, en bærer eller assosieres med en bærer, i hvilken bærer anti- akneformuleringen er uniformt distribuert, hvor anti- akneformuleringen omfatter effektive mengder av minst to aktive ingredienser fra minst to ulike grupper av aktive ingredienser og ved at minst to ulike grupper velges fra gruppen omfattende keratolytiske middel, anti- irritasjonsmiddel, anti-septiske middel, antimikrobielle middel, hormoner, hormon-agonister, hormon-antagonister og andre middel egnet for å behandle akne.
NO20021086A 1996-06-20 2002-03-05 Anordning for forsinket frigivelse av anti-aknemiddel NO20021086D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR96100207 1996-06-20
PCT/EP1997/003209 WO1997048387A1 (en) 1996-06-20 1997-06-19 Device for topical treatment of acne and its method of manufacture

Publications (2)

Publication Number Publication Date
NO20021086L true NO20021086L (no) 1999-02-18
NO20021086D0 NO20021086D0 (no) 2002-03-05

Family

ID=10942422

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021086A NO20021086D0 (no) 1996-06-20 2002-03-05 Anordning for forsinket frigivelse av anti-aknemiddel

Country Status (12)

Country Link
EP (1) EP1210937A3 (no)
JP (2) JP2000513347A (no)
KR (2) KR20000022054A (no)
CN (1) CN1398582A (no)
AU (1) AU732330B2 (no)
BR (1) BR9709920A (no)
HU (2) HU0200901D0 (no)
NO (1) NO20021086D0 (no)
RU (2) RU2197273C2 (no)
TR (1) TR199802659T2 (no)
YU (1) YU58998A (no)
ZA (1) ZA975489B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010000390A (ko) * 2000-09-26 2001-01-05 이영준 김치추출물을 함유하는 노화 및 여드름을 포함한피부개선제 혼합조성물
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
WO2004103321A2 (en) 2003-05-16 2004-12-02 Johnson & Johnson Consumer Companies, Inc. Topical treatment of ingrown hairs
US20050031571A1 (en) * 2003-05-16 2005-02-10 Khaiat Alain V. Topical treatment of ingrown hairs
SE526906C2 (sv) * 2003-06-10 2005-11-15 Moelnlycke Health Care Ab Metod att anbringa ett skyddsskikt på hud innehållande en högviskös silikonkomposition
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
JP5117196B2 (ja) * 2005-01-04 2013-01-09 テイコク ファーマ ユーエスエー インコーポレーテッド 冷却局所用貼付製剤
FR2894821B1 (fr) * 2005-12-15 2008-02-29 Galderma Res & Dev Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations
WO2009009135A1 (en) * 2007-07-11 2009-01-15 Dow Corning Corporation Compositions for delivering a drug
EP2143421A1 (en) * 2008-07-07 2010-01-13 Almirall Hermal GmbH Topical composition for the treatment of actinic keratosis
KR101221475B1 (ko) * 2009-12-07 2013-01-15 이성낙 여드름 개선용 화장료 조성물
WO2012153884A1 (ko) * 2011-05-12 2012-11-15 (주)아모레퍼시픽 안정성이 향상된 여드름 개선용 조성물
KR200470035Y1 (ko) * 2011-08-09 2013-11-25 웬-핑 왕 약용 밴드 구조체
DE102011111865A1 (de) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für 5-Aminolävulinsäurehydrochlorid
US11311423B2 (en) 2012-12-19 2022-04-26 Nichiban Co., Ltd. Facial patch
EP3067050A1 (en) * 2015-03-13 2016-09-14 Acino AG Transdermal therapeutic system with an overtape comprising two adhesive layers
CN110402127A (zh) * 2016-12-30 2019-11-01 优而美公司 含有改进的防粘衬里系统的贴片

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3893783A (en) * 1973-02-17 1975-07-08 Dowty Rotol Ltd Gas turbine engines and bladed rotors therefor
US3896789A (en) * 1974-06-10 1975-07-29 Riker Laboratories Inc Retinoic acid dipensing pressure sensitive dermotological tape
US4073291A (en) * 1976-07-28 1978-02-14 Johnson & Johnson Topical device for administering tretinoin
US4505896A (en) * 1979-04-19 1985-03-19 Elorac, Ltd. Method of treating acne vulgaris and composition
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
EP0299758B1 (en) * 1987-07-16 1994-12-14 The Regents Of The University Of California Compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins
US5156601A (en) * 1991-03-20 1992-10-20 Hydromer, Inc. Tacky, hydrophilic gel dressings and products therefrom
EP0639068A1 (en) * 1992-05-05 1995-02-22 The Procter & Gamble Company Acne treating composition
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery

Also Published As

Publication number Publication date
TR199802659T2 (xx) 1999-03-22
HUP0201299A2 (en) 2002-08-28
RU2197273C2 (ru) 2003-01-27
KR20000022054A (ko) 2000-04-25
JP2000513347A (ja) 2000-10-10
YU58998A (sh) 1999-09-27
KR20030097619A (ko) 2003-12-31
ZA975489B (en) 1998-03-27
EP1210937A2 (en) 2002-06-05
BR9709920A (pt) 2000-01-11
NO20021086D0 (no) 2002-03-05
HU0200901D0 (no) 2002-08-28
CN1398582A (zh) 2003-02-26
RU2002123419A (ru) 2004-03-20
AU732330B2 (en) 2001-04-12
JP2002284701A (ja) 2002-10-03
AU3340997A (en) 1998-01-07
EP1210937A3 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
NO985938L (no) Anordning for topikal behandling av akne og fremgangsmÕte ved fremstilling derav
NO20021086L (no) Anordning for forsinket frigivelse av anti-aknemiddel
Samartsev et al. The pH-dependent reciprocal changes in contributions of ADP/ATP antiporter and aspartate/glutamate antiporter to the fatty acid-induced uncoupling
Bunney et al. Electrophysiological effects of amphetamine on dopaminergic neurons
BR9810340A (pt) Sìntese e uso de compostos retinóides com atividades de hormÈnio negativo e/ou antagonistas
BR0007919A (pt) Composição purina 2,6,9-trisubstituìda
NZ330471A (en) Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors
NO940879L (no) Korrosjonsinhiberende blanding, samt anvendelse av denne
AR246663A1 (es) Composicion miticida y metodo para controlar concentraciones de aranuelas.
KR830007072A (ko) 활성화합물 방출효과가 우수한 탄성 액상플라스터형의 항진균제 조성물
BR9815582A (pt) Processo para inibir a corrosão em um sistema aquoso, e, composição aquosa para praticar o mesmo
BR9815342A (pt) Composição aquosa, e, processo para preparação e uso da mesma.
JPS5659710A (en) Preventive and remedy for psoriasis
KR970061246A (ko) 테스토스테론을 증가시키기 위한 약학 조성물
Urry et al. Monoamine oxidase activity of the hypothalamus and pituitary: Alterations after pinealectomy, changes in photoperiod, or additions of melatonin in vitro
BR9810711A (pt) Formulação tópica de pulverização antipruriginosa, e, processo para prevenção ou tratamento de prurido em um paciente
Selles et al. Nongenomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins
AR013163A1 (es) Uso de composiciones que contienen diclorofenil imidazoldioxolano para la preparacion de un medicamento para tratar la dermatitis seborreica, caspa,psoriasis y acne, composiciones propiamente dichas, y un articulo de fabricacion que contiene dicha composicion
PT90085A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica
JPS5230057A (en) Waste water treatment method
NO871001L (no) Antikonsepsjonsmiddel.
Thomas et al. NG-monomethyl L-arginine is a non-specific inhibitor of vascular relaxation
CO4960666A1 (es) Complejo de neutralizacion de cargas con arginilo de epro- sartan y un procedimiento para su produccion y formulacion
Dorigo et al. Lack of correlation between cyclic AMP synthesis and free fatty acid release in brown fat of cold-adapted rats
KR970061245A (ko) 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application